What to Know a 21 st Century Approach to Transgender Medical Care

Similar documents
DISCLOSURES LEARNING OBJECTIVES. 21st Century Strategies: Transgender Hormone Care. Patient/PCP. Medical model

Transgender Medicine beyond the guidelines.

10/07/18. Conflict of interest statement

Transgender Health Cases from the Transgender and Intersex Specialty Care Clinic

State of California, California Health and Human Services Agency, Department of Managed Health Care 2013:

Gender Health Center, Hormone Clinic th St #201 Sacramento, CA 95817

Transgender Medicine: Essentials for the Primary Care Provider BENJAMIN J. BOH, DO, MS

Guidelines for the Clinical Care of Persons with Gender Dysphoria

MODULE 1 F E M I N I Z I N G

Guidelines for the Clinical Care of Persons with Gender Dysphoria

Information About Hormonal Treatment for Trans women

Prescribing Guidelines

GUIDELINES FOR THE USE OF FEMINISING HORMONE THERAPY IN GENDER DYSPHORIA. Information for Primary Care December 2015 (Review Date June 2016)

Pharmacy Policy. Adult transgender hormonal therapy may be approved when all of the following criteria are met:

Hormone Therapy Overview for the Behavioral Health Provider. Julie Thompson, PA Fenway Health

North of Tyne and Gateshead Area Prescribing Committee GUIDELINES FOR THE USE OF FEMINISING HORMONE THERAPY IN GENDER DYSPHORIA

8/17/2015. Objectives. Disclosures

HEALTH CARE FOR TRANSGENDER PERSONS

Patient education for transgender feminizing hormone therapy

Disclosures. Endocrine Care of the Transgender Patient. Objectives. Start where you are. Use what you have. Do what you can. Vocabulary.

Care for Transgender Patient: Providing Competent and Compassionate Care During a Time of Transition

Endocrine Treatment of Gender-Dysphoric/ Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline. Education Module June, 2017

There are four areas where you can expect changes to occur as your hormone therapy progresses.

Oestrogen, progestogens and assessing risks of hormones. Dr Naomi Achong BSc MBBS(Hons) FRACP Endocrinologist

Fertility Issues for Transgender Persons. Timothy Cavanaugh, MD Fenway Health

Pharmacists' role in pharmacotherapy management of transgender patients

Providing Primary Care for Gender-Diverse Clients. Seaway Valley Community Health Centre June 30 th, 2016 Jennifer Douek, Jordan Zaitzow

HEALTH: Presented by: Alsean R. Bryant, Pharm.D., AAHIVP AIDS Healthcare Foundation

TRANSGENDER HEALTHCARE Barry Zevin, MD Conrad Wenzel, MSW

Endocrine Steroids 2. Signal transduction 3. Prostaglandins

Disclosures. Learning Objectives. Effects of Hormone Therapy on the Metabolic Syndrome and Cardiovascular Disease. None

Transgender Medicine in Primary Care. John-Paul Bettencourt, D.O., M.P.H., AAHIVS

THE YEAR IN REVIEW: SURGERY. Marta Bizic Faculty of Medicine, University of Belgrade, Serbia Belgrade Center for Genital Reconstructive Surgery

There are four areas where you can expect changes to occur as your hormone therapy progresses. 1) Physical

2-Hypertrichosis:- Hypertrichosis is the

Reproductive Health and Pituitary Disease

Medical Management of the Transgender Patient

Primary and HIV Care for Our Transgender Patients

Information About Hormonal Treatment for Trans men

Menopause. Medicines To Help You

Endocrinological Management and Treatment of Adult Gender Dysphoric. Patients

Feminising hormone treatment for trans women and non-binary people: Information for primary care professionals

CITY AND COUNTY OF SAN FRANCISCO

Hypogonadism 4/27/2018. Male Hypogonadism -- Definition. Epidemiology. Objectives HYPOGONADISM. Men with Hypogonadism. 95% untreated.

Endocrinology and the Transgender Patient

Integrating Transgender Health Care Into Our Medical Culture

Cross-Sex Hormone Therapy. Timothy Cavanaugh, MD Medical Director for Trans Health Program Fenway Health

HRT & TransCare Coordination. An intro the art of gender-affirming care

Transgender Populations

Class Review: Cross sex Hormone Therapy

INFORMED CONSENT FOR FEMINIZING HORMONE THERAPY

A Practitioner s Toolkit for the Management of the Menopause

A Guide to Feminizing Hormones Gender Affirming Care

National Gender Identity Clinical Network for Scotland (NGICNS)

Harold Husovsky, MD. Associate Professor of General Medicine at SUNY Health Science Center

Jamie Feldman M.D., Ph.D. Dept. of Family Medicine/Program in Human Sexuality University of Minnesota

Caring for Trans and Gender Diverse Clients in BC: A Primary Care Toolkit

Clinical Policy: Goserelin Acetate (Zoladex) Reference Number: ERX.SPA.145 Effective Date:

Arti Barnes MD MPH Tuesday AM series ENCOMPASSING THE MARGINALIZED: CARE FOR THE TRANSGENDER COMMUNITY

Cross-Sex Hormone Therapy. Timothy Cavanaugh, MD Medical Director for Trans Health Program Fenway Health

Transgender Medical Benefits

Treatment of hirsutism with a gonadotropin-releasing hormone agonist and estrogen replacement therapy*

2. Does the member have a diagnosis of central precocious puberty? Y N

Cross-Sex Hormone Therapy. Timothy Cavanaugh, MD Medical Director for Trans Health Team Fenway Health

A Guide to Masculinizing Hormones Gender Affirming Care

Metabolic Issues in Transgender Women Living With HIV. Jordan E. Lake, MD, MSc 2 November 2018

Gender Confirming Healthcare Across the Lifespan. Dr. Tracey Wiese, APRN, FNP-BC, PMHNP-BC

Medical management of Intersex disorders. Dr. Abdulmoein Al-Agha, Ass. Professor & Consultant Pediatric Endocrinologist KAAUH, Jeddah

Gender dysphoria an update for general physicians

Case Studies in Primary care

Class Review: Cross sex Hormone Therapy

Biology of Reproduction- Zool 346 Exam 2

Contraception and gynecological pathologies

Male Hypogonadism. Types and causes of hypogonadism. What is male hypogonadism? Symptoms. Testosterone production. Patient Information.

Please note that this should only be used for feedback and comments specifically related to this particular medical policy.

Horizon BCBSNJ Uniform Medical Policy Manual Policy Number: 115 Effective Date: 01/01/2017

Estrogens and progestogens

When testes make no testosterone: Identifying a rare cause of 46, XY female phenotype in adulthood

SHARED CARE PRESCRIBING GUIDANCE FOR

FLASH CARDS. Kalat s Book Chapter 11 Alphabetical

DINE AND LEARN ENDOCRINOLOGY PEARLS. Dr. Priya Manjoo, MD, FRCPC Endocrinology, Victoria, BC

ANDROGEN DEFICIENCY/MALE HYPOGONADISM

Testosterone Therapy in Men with Hypogonadism

Why do I need any hormone replacement? What is Menopause? What symptoms are treated by estrogen Injections?

presents with Ken Sekine, MD

Consent for Testosterone Therapy-Men Revised 4/10/18

Primary Care for Transgender Pa5ents. Objec5ves. Transgender 2/22/17. Charleston APRN Conference February 2017

Deciding whether or not to use Hormone Therapy (HT) is a big decision and should be

Client Information for Informed Consent FEMINIZING MEDICATIONS FOR TRANSGENDER CLIENTS

BioIdentical Hormone Replacement Therapy for Women

Sexual dysfunction of chronic kidney disease. Razieh salehian.md psychiatrist

Polycystic Ovary Syndrome HEATHER BURKS, MD OU PHYSICIANS REPRODUCTIVE MEDICINE SEPTEMBER 21, 2018

Hormonal Control of Human Reproduction

Implantable Hormone Pellets

Primary Care and Preventive Health Needs of Transgender Patients. Julie Thompson, PA-C Fenway Health

Androgen Deprivation Therapy (ADT) Following Recurring Prostate Cancer Or When Androgen Deprivation Becomes The Necessary Therapy

Biology of Reproduction-Biol 326

Topic 24: Estrogens and Female Reproductive Drugs

3 year old boy with puberty. Katie Stanley, MD August 1, 2013

Transcription:

What to Know a 21 st Century Approach to Transgender Medical Care Joshua Safer, MD Transgender Medicine Research Group Center for Transgender Medicine and Surgery

Patient / Mental Health Provider Gatekeeper Model Hormone Provider Surgeons

In the past decade, there has been greater acceptance of transgender care within conventional medical circles

Background Potential factors determining gender identity: 1. Environment 2. Societal construct 3. Passive response to anatomy 4. Biological

Evidence for the biological nature of gender identity Historical attempts to manipulate gender identity Twin studies Attempts to find brain anatomy associations with gender identity

If this biology what do we need to know?

Patient/PCP Medical model Endocrinology Specialist Mental Health Provider Surgeons other specialists

Presentation of Transgender Individuals presentation in adulthood is common and late adolescence more the norm than the exception. Articulation? Awareness? Not known. Fertility is addressed in an ad hoc fashion.

Strategy: December 11, 2011

Male hormones Female hormones Testosterone Estradiol Testosterone Estradiol

Current Approach to Therapy Adolescents: GnRH agonists at Tanner 2 Adult Transmen: androgen supplementation can be lifelong. Adult Transwomen: blockade to some degree of androgen production or action along with some degree of estrogen supplementation thrombosis concerns.

Primary Treatment Strategy Female to male: Titrate quickly to male serum testosterone levels But NB: I start at ½ dose --- 50-100 mg IM or SQ testosterone (enanthate or cypionate) q week; gel is fine; patches OK if tolerated Keep serum range 300-1000--

For F to M, follow T and androgen sensitive indexes Female to male: Follow - serum testosterone - CBC - lipid profile Don t neglect Pap smears, mammograms etc.

Treatment Strategy Male to female: Anti-androgens usually essential: Spironolactone -- may require high doses (100-400 mg/day 200 usual) -- other anti-androgens OK: Leuprolide (Lupron) Cyproterone acetate (in Europe)

Medical Treatment Strategy

Medical Treatment Strategy spironolactone Androgen receptors

spironolactone Known mechanism Safety Known pitfalls (K, BP) + Unknown mechanism

Medical Treatment Strategy

Medical Treatment Strategy GnRH agonists Very clear mechanism Effective Safety? Cost

progestins -- is there the logic?

progestins -- is there the logic? Lowers testosterone Anecdotal reference to areola Some data support modest virilization; most recent data suggest INCREASED prolactin Logic woman w/ uterus Concern for post-menopausal woman

5 α reductase inhibitors

Medical Treatment Strategy DHT (in tissues)

Medical Treatment Strategy 5 alpha reductase inhib. DHT (in tissues)

Expectations Modestly protective of scalp hair with male level androgens

Medical Treatment Strategy estrogens

Estrogens oral ----- estradiol 2-6 mg/day. ----- conjugated estrogens 2.5-7.5 mg/day ease, cost, horses vs lab ----- ethinyl estradiol - thromboses. ----- other (e.g. bio-equivalent ) quality control

estrogens injectable ----- estradiol valerate 5-20 mg IM every 1-2 weeks. estrogens other ----- transdermal (gel or patch) every day. (may have role for trans-men) ------ implantable

For M to F, follow T, estrogen sensitive indexes, and K Male to female: Follow - serum testosterone - estrogen level - K - lipid profile - prolactin

Health concerns long term? The only pitfalls known are HYPOGONADISM (osteoporosis and perhaps metabolic concerns) and SUPRA-PHYSIOLOGIC levels which may expose individuals to harm without known benefit (e.g. erythrocytosis with testosterone and thrombosis risk with estrogen).

Surgical Options Female to male: -- Chest Reconstruction * -- Genital Surgery (Phalloplasty) Male to female: -- Facial Feminization -- Genital Surgery (Vaginoplasty) * -- Breast Augmentation

Post-surgery (and aging) considerations Less estrogen Some estrogen Some testosterone

Only a minority of transgender individuals have surgery Increased acceptance of transgender people has 2 potentially competing results: 1. Access to surgery increased with more providers and better insurance coverage 2. Interest in surgery may decrease with greater societal acceptance.